Aprepitant: drug–drug interactions in perspective von Aapro, M.S., Walko, C.M.

Volltext

Functional characterization of variants of unknown significance (VUS) in patients and their responsiveness to targeted therapy drugs (TTD) von Tarcic, G., Walko, C.M., McLeod, H.L., Hicks, J.K., Barbash, Z., Edelheit, O., Miron, B., Vidne, M., Padron, E.

Volltext

Patients’ Understanding of How Genotype Variation Affects Benefits of Tamoxifen Therapy for Breast Cancer von Brewer, N.T., DeFrank, J.T., Chiu, W.K., Ibrahim, J.G., Walko, C.M., Rubin, P., Olajide, O.A., Moore, S.G., Raab, R.E., Carrizosa, D.R., Corso, S.W., Schwartz, G., Peppercorn, J.M., McLeod, H.L., Carey, L.A., Irvin, W.J.

Volltext

Identification of an AUC of 7603 Umol∗Min/Hr Per Day X 4 Days as the Maximum Tolerated Dose (MTD) of IV Continuous Infusion (CI) Busulfan (BU) with Fixed Dose Fludarabine (FLU) in... von Wood, W.A, Walko, C.M, Rao, K.V, Whitley, J, Moore, D.T, Gabriel, D.A, Serody, J.S, Coghill, J.M, Shea, T.C

Volltext

New Mechanistic Insight in the Thermal Helix Inversion of Second-Generation Molecular Motors von Klok, Martin, Walko, Martin, Geertsema, Edzard M., Ruangsupapichat, Nopporn, Kistemaker, Jos C. M., Meetsma, Auke, Feringa, Ben L.

Volltext